Related Experiment Video

Updated: May 26, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
13:20

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro

Published on: July 17, 2018

Inhibiting mitochondrial-dependent proteolysis of Mcl-1 promotes resistance to DNA damage

John R Mills1, Abba Malina, Jerry Pelletier

  • 1Department of Biochemistry, McGill University, Montréal, QC, Canada.

Cell Cycle (Georgetown, Tex.)
|December 22, 2011
PubMed

Insights

Myeloid leukemia cell 1 (Mcl-1) degradation is key for chemotherapy success. A new mitochondrial pathway for Mcl-1 breakdown is discovered, independent of the proteasome, offering novel therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Myeloid leukemia cell 1 (Mcl-1) is crucial for cell survival and chemotherapy response.
  • Mcl-1 proteolysis via the 26S proteasome is a known mechanism following DNA damage.
  • Tumor aggressiveness and poor prognosis are linked to Mcl-1 stabilization.

Purpose of the Study:

  • To characterize an alternative, proteasome-independent Mcl-1 degradation pathway.
  • To investigate the role of mitochondria in Mcl-1 proteolysis.
  • To explore the impact of the Akt/mTORC1 pathway on Mcl-1 stability.

Main Methods:

  • Investigated Mcl-1 proteolysis using proteasome-independent and mitochondrial-dependent assays.
  • Utilized a mitochondrial targeting signal located in the N terminus of Mcl-1.
  • Examined the effect of the Akt/mTORC1 survival pathway on Mcl-1 degradation.
  • Assessed Mcl-1 function ex vivo and in vivo in a mouse Eμ-Myc lymphoma model.

Main Results:

  • Identified a novel Mcl-1 proteolysis pathway dependent on mitochondria, not the proteasome.
  • Confirmed that the N-terminal mitochondrial targeting signal is essential for this alternative degradation.
  • Demonstrated that the Akt/mTORC1 pathway inhibits Mcl-1 mitochondrial-dependent proteolysis.
  • Disrupting Mcl-1 inner mitochondrial targeting enhanced its pro-survival capacity in vivo.

Conclusions:

  • Mitochondria play a critical role in Mcl-1 degradation through a proteasome-independent mechanism.
  • The N terminus of Mcl-1 is vital for its mitochondrial targeting and subsequent degradation.
  • The Akt/mTORC1 pathway regulates Mcl-1 stability by preventing its mitochondrial degradation.
  • Targeting Mcl-1 mitochondrial localization represents a potential therapeutic strategy in cancer.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.